News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
215,134 Results
Type
Article (7681)
Company Profile (38)
Press Release (207415)
Multimedia
Podcasts (26)
Webinars (5)
Section
Business (56451)
Career Advice (219)
Deals (10789)
Drug Delivery (47)
Drug Development (12746)
Employer Resources (45)
FDA (5869)
Job Trends (5448)
News (88463)
Policy (8773)
Tag
Academia (737)
Accelerated approval (1)
Adcomms (1)
Allergies (31)
Alliances (15614)
ALS (14)
Alzheimer's disease (341)
Antibody-drug conjugate (ADC) (26)
Approvals (5934)
Artificial intelligence (165)
Autoimmune disease (6)
Automation (5)
Bankruptcy (67)
Best Places to Work (4949)
BIOSECURE Act (4)
Biosimilars (56)
Biotechnology (20)
Bladder cancer (28)
Brain cancer (5)
Breast cancer (99)
Cancer (597)
Cardiovascular disease (71)
Career advice (203)
Career pathing (3)
CAR-T (25)
Cell therapy (96)
Cervical cancer (7)
Clinical research (10895)
Collaboration (307)
Compensation (28)
Complete response letters (2)
COVID-19 (751)
CRISPR (13)
C-suite (108)
Cystic fibrosis (19)
Data (688)
Decentralized trials (1)
Denatured (11)
Depression (14)
Diabetes (92)
Diagnostics (3257)
Digital health (12)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (37)
Drug pricing (47)
Drug shortages (6)
Duchenne muscular dystrophy (34)
Earnings (18206)
Editorial (17)
Employer branding (2)
Employer resources (40)
Events (48656)
Executive appointments (311)
FDA (6378)
Frontotemporal dementia (3)
Funding (283)
Gene editing (30)
Generative AI (18)
Gene therapy (78)
GLP-1 (185)
Government (1377)
Grass and pollen (2)
Guidances (33)
Healthcare (8741)
Huntington's disease (2)
IgA nephropathy (14)
Immunology and inflammation (22)
Indications (13)
Infectious disease (804)
Inflammatory bowel disease (41)
Inflation Reduction Act (5)
Influenza (15)
Intellectual property (21)
Interviews (22)
IPO (4361)
IRA (16)
Job creations (730)
Job search strategy (188)
Kidney cancer (1)
Labor market (6)
Layoffs (76)
Legal (1673)
Liver cancer (16)
Lung cancer (82)
Lymphoma (39)
Machine learning (3)
Management (19)
Manufacturing (89)
MASH (23)
Medical device (6235)
Medtech (6235)
Mergers & acquisitions (6696)
Metabolic disorders (240)
Multiple sclerosis (37)
NASH (5)
Neurodegenerative disease (19)
Neuropsychiatric disorders (8)
Neuroscience (477)
NextGen: Class of 2025 (2948)
Non-profit (1575)
Now hiring (3)
Obesity (128)
Opinion (71)
Ovarian cancer (15)
Pain (21)
Pancreatic cancer (13)
Parkinson's disease (24)
Partnered (8)
Patents (45)
Patient recruitment (35)
Peanut (19)
People (18916)
Pharmaceutical (12)
Pharmacy benefit managers (8)
Phase I (2323)
Phase II (3824)
Phase III (5212)
Pipeline (416)
Policy (48)
Postmarket research (737)
Preclinical (763)
Press Release (11)
Prostate cancer (37)
Psychedelics (6)
Radiopharmaceuticals (77)
Rare diseases (112)
Real estate (1436)
Recruiting (16)
Regulatory (6441)
Reports (16)
Research institute (648)
Resumes & cover letters (20)
Rett syndrome (3)
RNA editing (1)
RSV (17)
Schizophrenia (20)
Series A (45)
Series B (39)
Service/supplier (3)
Sickle cell disease (26)
Special edition (6)
Spinal muscular atrophy (35)
Sponsored (6)
Startups (1270)
Stomach cancer (3)
Supply chain (24)
Tariffs (14)
The Weekly (15)
Vaccines (165)
Venture capitalists (17)
Weight loss (66)
Women's health (21)
Worklife (3)
Date
Today (51)
Last 7 days (278)
Last 30 days (837)
Last 365 days (11826)
2025 (4216)
2024 (12221)
2023 (13337)
2022 (20481)
2021 (21869)
2020 (21226)
2019 (18117)
2018 (13344)
2017 (9161)
2016 (9761)
2015 (11227)
2014 (8296)
2013 (6813)
2012 (7112)
2011 (7099)
2010 (5710)
Location
Africa (239)
Alabama (14)
Alaska (1)
Arizona (71)
Arkansas (6)
Asia (11278)
Australia (1513)
California (1840)
Canada (658)
China (170)
Colorado (126)
Connecticut (110)
Delaware (51)
Europe (27105)
Florida (326)
Georgia (98)
Hawaii (1)
Idaho (19)
Illinois (230)
India (19)
Indiana (143)
Iowa (1)
Japan (82)
Kansas (23)
Kentucky (14)
Louisiana (8)
Maine (26)
Maryland (250)
Massachusetts (1470)
Michigan (97)
Minnesota (136)
Mississippi (2)
Missouri (55)
Montana (5)
Nebraska (13)
Nevada (19)
New Hampshire (26)
New Jersey (721)
New Mexico (9)
New York (634)
North Carolina (412)
North Dakota (1)
Northern California (818)
Ohio (70)
Oklahoma (8)
Oregon (11)
Pennsylvania (532)
Puerto Rico (3)
Rhode Island (9)
South America (322)
South Carolina (10)
Southern California (687)
Tennessee (72)
Texas (260)
United States (8040)
Utah (107)
Virginia (48)
Washington D.C. (25)
Washington State (152)
West Virginia (3)
Wisconsin (27)
215,134 Results for "quantum leap healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evinova and Quantum Leap Healthcare Partner to Incorporate Real-Time Remote Patient Monitoring into Breast Cancer Platform Trial
March 20, 2025
·
3 min read
Press Releases
Esphera SynBio Announces New Project to Advance Next Generation mRNA Vaccine Development, supported by the CQDM Quantum Leap program
January 10, 2025
·
2 min read
Press Releases
Quantum BioPharma Corporate Update
April 21, 2025
·
4 min read
Press Releases
Quantum BioPharma Provides Corporate Update
March 31, 2025
·
4 min read
Drug Development
Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah Therapeutics, and the Menarini Group
Quantum Leap Healthcare Collaborative (QLHC) announces the enrollment launch for the Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: Ductal Carcinoma In Situ (RECAST DCIS), a Phase 2 platform study aimed at preventing the progression of DCIS to breast cancer.
October 30, 2023
·
6 min read
Business
Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial
Atossa Therapeutics, Inc. and Quantum Leap Healthcare Collaborative™ (“Quantum Leap”) today announced that six patients have been dosed with Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, in the ongoing Phase 2 I-SPY 2 clinical trial.
June 28, 2023
·
6 min read
Earnings
Lilly’s Revenue Leaps 45% Thanks to Zepbound, Mounjaro, Of Course
To say, as CEO David Ricks did, that this was a good quarter, is an understatement. Mounjaro in diabetes brought in $3.84 billion for the quarter while Zepbound in weight loss booked $2.31 billion.
May 1, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
IonQ Reaches Important Milestone in Achieving Faster Quantum Gates for Quantum Computing and Networking
March 5, 2025
·
6 min read
Press Releases
Simplex Quantum and the University of Tokyo Announce Breakthrough AI Technology for Heart Failure Monitoring
April 24, 2025
·
3 min read
Press Releases
Quantum BioPharma Unaware of Any Material Change
March 17, 2025
·
1 min read
1 of 21,514
Next
